75 Results

People

  1. Gerecitano
    Gerecitano
  2. Zelenetz
    Zelenetz
  3. Moskowitz
    Moskowitz
  4. Hamlin
    Hamlin
  5. Noy
    Noy
  6. Matasar
    Matasar
  7. Portlock
    Portlock
  8. Younes
    Younes
  9. Palomba
    Palomba
  10. Horwitz
    Horwitz

Groups

  1. Center for Hematologic Malignancies (75)
  2. Department of Medicine (75)
  3. Hematologic Malignancies, Division of (75)
  4. Lymphoma (75)
  5. Survivorship Research (50)
  6. Executive Committee, Center for Hematologic Malignancies (44)
  7. Population Sciences Research Program (42)
  8. Nursing (36)
  9. Epidemiology and Biostatistics (35)
  10. Biostatistics Service (30)
  1. "Center for Hematologic Malignancies"
  2. "Lymphoma"
  3. "John Gerecitano"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (25)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (75)
  2. Department of Medicine (75)
  3. Hematologic Malignancies, Division of (75)
  4. Lymphoma (75)
  5. Survivorship Research (50)
  6. Executive Committee, Center for Hematologic Malignancies (44)

More Groups

People
  1. John Gerecitano (75)
  2. Andrew Zelenetz (62)
  3. Paul Hamlin (60)
  4. Craig Moskowitz (57)
  5. David Straus (56)
  6. Ariela Noy (50)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (4)

More Years

Publications
  1. Blood (29)
  2. Journal of Clinical Oncology (14)
  3. Haematologica (5)
  4. Hematological Oncology (5)
  5. Annals of Oncology (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Hematology (30)
  2. American Society of Clinical Oncology (14)
  3. Wiley Blackwell (6)
  4. Ferrata Storti Foundation (5)
  5. American Association for Cancer Research (4)
  6. Oxford University Press (4)

More Publishers

Results (75)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
    Journal Article

    Lin, R. J.; Owens, C. N.; Drill, E.; Iannotta, A.; Oliveros, M.; Schick, D. L.; Noy, A.; Gerecitano, J. F.; Drullinsky, P. R.; Caron, P. C.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue
    Journal Article

    Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
    Journal Article

    Joffe, E.; Leyfman, Y.; Drill, E.; Rajeeve, S.; Zelenetz, A. D.; Lia Palomba, M.; Moskowitz, C. H.; Portlock, C.; Noy, A.; Horwitz, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Gerecitano, J. F.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
    Journal Article

    Borchmann, S.; Joffe, E.; Moskowitz, C. H.; Zelenetz, A. D.; Noy, A.; Portlock, C. S.; Gerecitano, J. F.; Batlevi, C. L.; Caron, P. C.; Drullinsky, P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Zelenetz, A. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Laraque, L.; more...
    Blood (2018)

    Fulltext@MSK | Save